Max Stevenson

Dr. Stevenson is a postdoctoral fellow in the departments of pharmacology and neuroscience investigating the efficacy of senolytic therapies as treatments for post-traumatic epilepsy. His PhD thesis involved developing novel small molecule tyrosine kinase inhibitors as treatments for reducing pathology in Alzheimer’s Disease. His is the recipient of a TL1 translational research grant from the Georgetown-Howard Universities Center for Clinical and Translational Science to receive training in leading translational collaborative research teams towards discovering novel treatments for neurodegenerative diseases.

Academic Appointment(s)

Secondary
Post Doctoral Fellow, Forcelli Lab
Post Doctoral Fellow, Burns Lab, Dept of Neuroscience